Mounjaro 5 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FXLD8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $69,296
Award facts
- Contract value 100% obligated
- $69,296.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $69,296.15 delivery order to AmerisourceBergen Drug Corp for Mounjaro 5 mg/0.5 ml pen injectors on July 29, 2025, with completion targeted for July 30, 2025. This firm fixed-price delivery order was competitively awarded without a set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Mounjaro is a diabetes management medication used to improve glycemic control in patients with type 2 diabetes, reflecting DLA's ongoing pharmaceutical supply needs for military healthcare systems.
This delivery order is issued under AmerisourceBergen's $999,999,999 IDC with DLA Troop Support Medical (SPE2DX contract), which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide. AmerisourceBergen is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, with an extensive portfolio of brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The award demonstrates the company's capability to meet federal procurement requirements in open competition and support the Defense Health Agency and other government healthcare systems through flexible contract mechanisms.
Quick answers
Who was awarded contract SPE2DB25FXLD8?
SPE2DB25FXLD8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 29, 2025.
How much is contract SPE2DB25FXLD8 worth?
The government has obligated $69,296 on SPE2DB25FXLD8.
Is contract SPE2DB25FXLD8 an order under another contract?
Yes. SPE2DB25FXLD8 is a delivery order under SPE2DB24D2003, an indefinite delivery contract.
Was contract SPE2DB25FXLD8 competed?
The extent of competition for SPE2DB25FXLD8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award